. Effects of PAR-1 and aPKC modulation on neuronal differentiation in Xenopus embryos (A) PAR-1 MO inhibits translation of PAR-1 RNA in vivo. Embryos were injected at the two-cell stage with MOs and untagged PAR-1 RNA at indicated doses. Lysates collected at stage 10.5-11 were analyzed by western blotting with anti-PAR-1 or anti-tubulin antibodies. Asterisk marks the band corresponding to PAR-1 protein, which is depleted by PAR-1BY MO injection. 
(F) Quantification of the effects of PAR-1 on Hox11L2 and Xaml expression, presented as percentage of embryos with altered gene expression. (G-I) Cross sections of embryos analyzed by wholemount in situ hybridization with N-tubulin (N-tub) anti-sense probe (stages 14-16) injected with indicated RNA or MO. Injected side is to the right, midline is indicated by a dotted line. Arrows point to altered gene expression at the injected side. Figure 2C . (F) C17.2 cells with manipulated PAR-1 and aPKC levels grow at different rates. Lentivirus-infected C17.2 cells were plated at equal density and the number of viable cells was determined at different time intervals after differentiation was induced. Scale bar is 20 µm. (E and F) Results are presented as the means ± s. d. for three independent experiments. (C) PAR-1 MO increases Mib protein levels at the neurula stages. Embryos were injected at the two-cell stage with MOs and MycMib RNA(0.3 ng) as indicated. Lysates from embryos at stage 13 were analyzed by Western blotting with anti-Myc or anti-tubulin antibodies. PAR-1 MO, but not control MO (CO MO) upregulates Mib at both stages, but has no effect on α-tubulin levels.
Figure S5. PAR-1 does not influence Notch ICD signaling.
Embryos were injected with Notch ICD and PAR-1 RNAs at indicated doses as described in Figure 1 and processed for in situ hybridization with the N-tubulin probe. Representative images are shown.
SUPPLEMENTAL EXPERIMENTAL PROCEDURES
DNA constructs, RNA synthesis, morpholino oligonucleotides and mutagenesis Plasmids encoding Xenopus Myc-and GFP-tagged PAR-1, PAR-1T560A, and PAR-1KD, untagged PAR-1, Flag-aPKC-CAAX (Ossipova et al., 2005; , Dll1-Myc, Dll1∆C (also known as XDelta Stu mutant), Notch-ICD, zebrafish Flag-Mib, Flag-MibC1001S, Myc-Mib, Myc-MibC1001S (Chitnis et al., 1995 Coffman et al., 1993; Deblandre et al., 2001; Itoh et al., 2003) have been described. For GFP-aPKC-CAAX, aPKC-CAAX was amplified and inserted into the Eco RI site of pXT7-EGFP (Itoh et al., 2000) . Untagged Dll1 was amplified from Dll1-Myc by Pfu polymerase and subcloned into Eco RI and Xho I sites of pCS2+. pGEM-HA-Ub and pBSSK-HA-Ub constructs were generated by subcloning the Not I/Kpn I fragment containing 8xHA-Ub from pMT123 (Treier et al., 1994) . Dll1∆C was derived from Pfu-amplified first 1752 base pairs of the Dll1 open reading frame, subcloned into the Bam HI site of pCS2+. Dll1∆C-Ub and Dll1∆C-Ub-HA were generated by inserting the sequence encoding ubiquitin from pMT123 (Treier et al., 1994) into the Xba I site of Dll1∆C and Dll1∆C-HA (Chitnis et al., 1995; Deblandre et al., 2001; Itoh et al., 2003) . Subcloning was verified by sequencing. Details of cloning are available on request. Mib phosphorylation mutants have been generated in pCS3 via single-primer-based mutagenesis essentially as described (Itoh et al., 2005; Makarova et al., 2000) . Mutations were verified by sequencing. The following primers were used: M1 (S143A/T147R) 5'-cgcaagtcgaagaagatcAGGgcccgcggcatctttgca-3', changed sequence is underlined; M2 (T278A/T280A/T281A/T284A), 5'-ggcatgttcgagacgctcGCCGCGGCGggcGCCgtcgtctgcggcatcgacgaag-3';
